Legal & General Group PLC Celldex Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 68,543 shares of CLDX stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,543
Previous 68,543 -0.0%
Holding current value
$1.61 Million
Previous $2.33 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$32.06 - $44.56 $149,175 - $207,337
4,653 Added 7.28%
68,543 $2.33 Million
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $245,175 - $318,519
7,484 Added 13.27%
63,890 $2.36 Million
Q1 2024

May 14, 2024
BUY
$35.22 - $51.88 $154,756 - $227,960
4,394 Added 8.45%
56,406 $2.37 Million
Q4 2023

Feb 15, 2024
BUY
$22.61 - $40.65 $252,508 - $453,979
11,168 Added 27.34%
52,012 $2.06 Million
Q3 2023

Nov 14, 2023
BUY
$25.45 - $37.46 $98,567 - $145,082
3,873 Added 10.48%
40,844 $1.12 Million
Q2 2023

Aug 14, 2023
BUY
$30.29 - $38.28 $549,763 - $694,782
18,150 Added 96.43%
36,971 $1.25 Million
Q1 2023

May 15, 2023
BUY
$34.78 - $47.43 $55,856 - $76,172
1,606 Added 9.33%
18,821 $677,000
Q4 2022

Feb 14, 2023
BUY
$27.78 - $45.38 $10,000 - $16,336
360 Added 2.14%
17,215 $767,000
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $16,593 - $27,463
731 Added 4.53%
16,855 $474,000
Q2 2022

Aug 22, 2022
SELL
$20.5 - $37.33 $13,366 - $24,339
-652 Reduced 3.89%
16,124 $435,000
Q1 2022

May 16, 2022
BUY
$27.64 - $39.32 $7,158 - $10,183
259 Added 1.57%
16,776 $572,000
Q4 2021

Feb 14, 2022
SELL
$35.68 - $56.27 $9,027 - $14,236
-253 Reduced 1.51%
16,517 $638,000
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $308,809 - $597,245
10,667 Added 174.78%
16,770 $906,000
Q2 2021

Aug 12, 2021
BUY
$20.71 - $35.37 $91,165 - $155,698
4,402 Added 258.79%
6,103 $204,000
Q4 2020

Feb 12, 2021
BUY
$14.99 - $22.75 $25,497 - $38,697
1,701 New
1,701 $30,000

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.1B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email